As women continue to file complaints with the U.S. Food and Drug Administration (FDA) over transvaginal mesh implants, claims over C.R. Bard mesh products marketed under the company’s brand of Avaulta devices have been brought on behalf of patients who allegedly sustained injuries.
Implants at the center of Bard Avaulta lawsuits pending in federal and state courts in the U.S. include:
Plaintiffs in Bard mesh cases allege implantation of the above devices may lead to complications such as mesh erosion, infection, chronic pain, organ perforation and vaginal scarring.
Many of the lawsuits over these products are pending in a federal litigation (MDL) underway in the U.S. District Court for the Southern District of West Virginia. There, four bellwether trials were selected to head to trial beginning in June of 2013. The first trial date is set for June 11, 2013, according to an Order issued by the Court on March 7th, 2013. (In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation “MDL No. 2187”)
Two months later, the Court denied a motion by C.R. Bard to seal certain e-mails involving information about its suppliers after they were filed as exhibits by plaintiffs. C.R. Bard’s motion stated the emails would reveal trade secrets and other confidential company information.
Meanwhile, a consolidated litigation of Bard Avaulta mesh lawsuits has been created in New Jersey Superior Court in Atlantic County, where court records indicate hundreds of claims have been filed. Court documents show the first trial for these lawsuits will begin in September 2013.
Bernstein Liebhard LLP remains active in both of these litigations with Firm partner Jeffrey S. Grand serving on the Plaintiffs’ Steering Committee in the federal proceeding, and as Co-Liaison Counsel for the state court cases.
In July 2012, the first plaintiff in a transvaginal mesh lawsuit won $5.5 million in damages after a jury in Caliofrnia ruled that the woman’s Bard Avaulta Plus caused her chronic pain, an inability to have sex, and with recurring stress urinary incontinence (SUI). Jurors found C.R. Bard to be guilty of failing to warn women about the safety risks associated with its vaginal mesh implants.
What’s more, the transvaginal mesh implants could not be safely removed, her lawsuit asserted, even after eight revision surgeries and nine other operations to correct the complications they caused.
If you received a Bard Avaulta mesh device, the urinary problems, pain and other injuries you may have suffered may have been a result of your transvaginal mesh implant. Call an attorney at Bernstein Liebhard LLLP to find out more about lawsuits involving this brand of devices at .